FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

90 letters match. Newest first.

  1. Chongqing Qiancan Technology Co., Ltd.

    Chongqing Qiancan Technology, an API maker in China, refused FDA records requests; FDA placed its drugs on import alert 66-79.

    High risk
  2. Tianjin Healthcare Medical Technology Co., Ltd.

    Chinese API maker refused FDA records requests, and all its drugs now face a US import alert.

    High risk
  3. Lovelace Biomedical Research Institute

    Lovelace Biomedical's quality unit failed to ensure final drug study reports matched raw data, FDA says.

    Medium
  4. VeganicSKN Limited

    FDA warns VeganicSKN over manufacturing rule failures; drug shipped after failing test and high-risk ingredient not identity-tested.

    High risk
  5. Aeroflex Industria de Aerosol Ltda.

    Brazil OTC drug maker Aeroflex ignored FDA records requests, prompting possible approval holds and US shipment refusals.

    High risk
  6. HealthPartners Neuroscience Center Research and Innovation

    FDA warned HealthPartners Neuroscience Center that its animal studies of an investigational drug violated good laboratory practice rules.

    Medium
  7. Intas Pharmaceuticals Limited

    FDA warns Intas Pharmaceuticals' Dehradun, India plant over weak out-of-spec investigations and untracked batch-record edits for its tablets.

    High risk
  8. Vedic Lifesciences Pvt. Ltd.

    FDA warns Vedic Lifesciences over false final reports for three nonclinical drug studies.

    Medium
  9. Palamur Biosciences Private Limited

    FDA warns Palamur Biosciences over GLP violations in medical device safety testing and inadequate corrective actions.

    High risk
  10. Persōn & Covey, Inc.

    FDA cites Persōn & Covey for CGMP failures at its Glendale, CA drug plant and for selling unapproved Xerac AC and Drysol.

    High risk
  11. Media Networks Sydney Pty. Limited

    FDA says Australia's Media Networks Sydney failed to answer drug records requests for OTC Combantrin Chocolate Squares.

    High risk
  12. Jiangsu Kerbio Medical Technology Group Co.

    FDA cites Jiangsu Kerbio Medical Technology Group for serious GLP violations in medical device safety testing.

    High risk
  13. CCIC Huatongwei International Inspection Co., Ltd.

    FDA warns CCIC Huatongwei after inspection found copied data and missing records in medical device safety tests.

    High risk
  14. Kenil Healthcare Private Limited

    FDA warns Kenil Healthcare over adulterated drugs from India due to cleaning, packaging, and quality failures.

    High risk
  15. Viatris, Inc.

    FDA warns Viatris that its Indore, India, drug plant had unreliable quality data and weak investigations.

    High risk
  16. Mid-Link Testing Company, Ltd

    FDA warns Mid-Link Testing over unreliable Good Laboratory Practice (GLP) safety data for medical device tests.

    High risk
  17. Sanitation & Environmental Technology Institute dba SDWH

    FDA found GLP violations in SDWH's nonclinical testing of medical devices, raising doubts about safety data.

    High risk
  18. Jiangsu Shenli Medical Production Co., Ltd.

    FDA: Chinese syringe maker Jiangsu Shenli lacked design controls and device master records, halting US imports.

    High risk
  19. Jiangsu Hengrui Pharmaceuticals Co., Ltd.

    FDA found data integrity failures and inadequate sterile manufacturing controls at Jiangsu Hengrui Pharmaceuticals' drug facility.

    High risk
  20. Cipla Limited

    FDA warned Cipla about unresolved albuterol inhaler delivery complaints and contamination in sterile manufacturing at its Indore site.

    High risk
  21. Samm Solutions, Inc., d.b.a. BTS Research

    Samm Solutions/BTS Research failed good laboratory practice (GLP) rules for nonclinical drug studies, FDA says.

    Medium
  22. Hygienic Labs, LLC

    Hygienic Labs, an OTC drug manufacturer, failed to respond to FDA records requests.

    Medium
  23. Zhao Qing Longda Biotechnology Co. Ltd.

    FDA says Zhao Qing Longda Biotechnology refused records access for OTC drugs, including children’s toothpaste, and placed its drugs on import alert.

    High risk
  24. Gulf States International, Inc.

    Gulf States International refused FDA requests for OTC drug manufacturing records, FDA says.

    Medium
  25. Maison Blanche LLC

    FDA warns Maison Blanche for refusing repeated requests for records on its OTC hand sanitizer.

    Medium
  26. Integra LifeSciences Corporation

    FDA warned Integra LifeSciences over collagen-based medical devices made in Boston after an inspection found quality-system failures and endotoxin testing problems.

    High risk
  27. Cergomex Imports, LLC

    Cergomex Imports, an over-the-counter drug manufacturer, refused FDA records requests for its Sanetto Hands Sanitizer Gel.

    Medium
  28. GTP International Corp

    GTP International, a Mesquite, TX maker of OTC hand sanitizer, refused FDA's repeated requests for manufacturing records.

    Medium
  29. Skyline Herbals Private Limited

    FDA warns India's Skyline Herbals after it ignored records requests for OTC drugs including toothpaste; all its drugs hit Import Alert 66-79.

    High risk
  30. ZYTO Technologies, Inc.

    FDA warns ZYTO over unapproved disease claims for Hand Cradle GSR and quality-system failures.

    High risk
  31. Chengdu KeCheng Fine Chemicals Co., Ltd.

    FDA placed Chengdu KeCheng's APIs on import alert after it ignored FDA records requests.

    High risk
  32. Drivergent, Inc.

    Drivergent's hand sanitizers had acetaldehyde and acetal above allowed limits, FDA says.

    High risk
  33. NuGeneration Technologies LLC

    FDA inspected NuGeneration Technologies' Emeryville, California drug plant and found CGMP failures in hand sanitizer release testing, ingredient and water testing, stability and process validation.

    High risk
  34. Kobayashi Healthcare International, Inc.

    Kobayashi's Georgia plant released Zim's OTC pain drugs without microbial testing and lacked quality unit oversight, FDA says.

    High risk
  35. Mohawk Laboratories Division of NCH Corporation

    FDA warns Mohawk Laboratories that its hand sanitizer contained unacceptable acetaldehyde and acetal impurities.

    High risk
  36. Urban Electric Power

    Urban Electric Power hand sanitizers contained unacceptable acetaldehyde and acetal impurities and had CGMP violations.

    High risk
  37. Empowered Diagnostics LLC

    Empowered Diagnostics distributed COVID-19 test kits without FDA approval or emergency authorization, and some labeling falsely said they were authorized.

    High risk
  38. The Anthos Group, Inc.

    Anthos Group refused FDA access to OTC drug records for VERTRA Hand Sanitizer, FDA says.

    Medium
  39. Valley Biosystems

    FDA cited Valley Biosystems, a California biologics testing lab, for Good Laboratory Practice violations that call its nonclinical study data into question.

    High risk
  40. Jose Miguel Gutierrez Salas

    FDA says hand sanitizer declared made by Jose Miguel Gutierrez Salas had methanol, not ethanol, and firm was not FDA-registered.

    High risk
  41. Guangzhou Orchard Aromatherapy & Skin Care Co., Ltd.

    Guangzhou Orchard Aromatherapy & Skin Care refused FDA records requests for its over-the-counter hand sanitizers, leading to import alert.

    High risk
  42. DDI Multinacional S.A. de C.V.

    DDI Multinacional hand sanitizers labeled 70% ethanol contained up to 60% methanol, leading to adulteration and import alert.

    High risk
  43. Noticias Mexico Hoy Grupo Multimedia, S.A. de C.V.

    Noticias Mexico Hoy Grupo Multimedia's hand sanitizer labeled as ethanol was found to contain methanol.

    High risk
  44. Mirfeel Korea Co., Ltd.

    Mirfeel Korea's hand sanitizer contained benzene and had testing failures; FDA also says food-pouch packaging misbranded.

    High risk
  45. Industrias Cklass S. de R.L. de C.V.

    FDA found Industrias Cklass hand sanitizer labeled 70% ethanol contained 19% ethanol and 48% methanol and was refused U.S. admission.

    High risk
  46. David Cosmetic Co., Ltd.

    FDA lab testing found benzene, a cancer-causing impurity, at about 6 ppm in David Cosmetic's CALA hand sanitizer, making it adulterated.

    High risk
  47. Toxikon Corporation/Labcorp Bedford LLC

    FDA warned Toxikon/Labcorp Bedford over GLP violations in a biologics nonclinical study, including incorrect kidney-function calculations and failed QA review.

    Medium
  48. Maquiladora Miniara SA de CV

    Maquiladora Miniara's Shine and clean Hand Sanitizer Gel was found to contain methanol instead of labeled ethanol.

    High risk
  49. Guangdong Kemei Pharmaceutical Technology Co. Ltd.

    FDA says Guangdong Kemei's IMC hand sanitizer labeled 75% ethanol contained methanol and was refused at U.S. border.

    High risk
  50. Guangzhou Shiruoni Cosmetics Co., Ltd

    Guangzhou Shiruoni Cosmetics' hand sanitizer labeled as 75% isopropyl alcohol contained ethanol instead and was misbranded as FDA-approved.

    High risk